{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:59:42Z","timestamp":1793743182113,"version":"4.6.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Borgny Kleppe's Legacy"},{"name":"Jan A. Pahle's Legacy"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13075-016-1201-0","type":"journal-article","created":{"date-parts":[[2017,1,12]],"date-time":"2017-01-12T12:27:15Z","timestamp":1484224035000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["Calprotectin (S100A8\/A9) has the strongest association with ultrasound-detected synovitis and predicts response to biologic treatment: results from a longitudinal study of patients with established rheumatoid arthritis"],"prefix":"10.1186","volume":"19","author":[{"given":"Hilde Haugedal","family":"Nordal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl Albert","family":"Brokstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magne","family":"Solheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Kristine","family":"Halse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tore K.","family":"Kvien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilde Berner","family":"Hammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,12]]},"reference":[{"issue":"23","key":"1201_CR1","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","volume":"365","author":"IB McInnes","year":"2011","unstructured":"McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365(23):2205\u201319.","journal-title":"N Engl J Med"},{"issue":"4","key":"1201_CR2","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1023\/A:1009229508096","volume":"2","author":"EM Paleolog","year":"1998","unstructured":"Paleolog EM, Miotla JM. Angiogenesis in arthritis: role in disease pathogenesis and as a potential therapeutic target. Angiogenesis. 1998;2(4):295\u2013307.","journal-title":"Angiogenesis"},{"issue":"1","key":"1201_CR3","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/ajcp\/84.1.24","volume":"84","author":"I Dale","year":"1985","unstructured":"Dale I, Brandtzaeg P, Fagerhol MK, Scott H. Distribution of a new myelomonocytic antigen (L1) in human peripheral blood leukocytes. Immunofluorescence and immunoperoxidase staining features in comparison with lysozyme and lactoferrin. Am J Clin Pathol. 1985;84(1):24\u201334.","journal-title":"Am J Clin Pathol"},{"issue":"12","key":"1201_CR4","first-page":"2523","volume":"26","author":"P Youssef","year":"1999","unstructured":"Youssef P, Roth J, Frosch M, Costello P, Fitzgerald O, Sorg C, et al. Expression of myeloid related proteins (MRP) 8 and 14 and the MRP8\/14 heterodimer in rheumatoid arthritis synovial membrane. J Rheumatol. 1999;26(12):2523\u20138.","journal-title":"J Rheumatol"},{"key":"1201_CR5","first-page":"187","volume-title":"Stimulus response coupling: the role of intracellular calcium-binding proteins","author":"MK Fagerhol","year":"1990","unstructured":"Fagerhol MK, Andersson KB, Naess-Andresen CF, Brantzaeg P, Dale I. Calprotectin (the L1 leukocyte protein). In: Smith VL, Dedman JR, editors. Stimulus response coupling: the role of intracellular calcium-binding proteins. Boca Raton, FL: CRC Press; 1990. p. 187\u2013210."},{"issue":"Pt 2","key":"1201_CR6","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1042\/bj3090395","volume":"309","author":"F Guignard","year":"1995","unstructured":"Guignard F, Mauel J, Markert M. Identification and characterization of a novel human neutrophil protein related to the S100 family. Biochem J. 1995;309(Pt 2):395\u2013401.","journal-title":"Biochem J"},{"issue":"3","key":"1201_CR7","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.clim.2012.11.008","volume":"147","author":"C Kessel","year":"2013","unstructured":"Kessel C, Holzinger D, Foell D. Phagocyte-derived S100 proteins in autoinflammation: putative role in pathogenesis and usefulness as biomarkers. Clin Immunol. 2013;147(3):229\u201341.","journal-title":"Clin Immunol"},{"issue":"11","key":"1201_CR8","first-page":"1416","volume":"16","author":"HB Berntzen","year":"1989","unstructured":"Berntzen HB, Munthe E, Fagerhol MK. A longitudinal study of the leukocyte protein L1 as an indicator of disease activity in patients with rheumatoid arthritis. J Rheumatol. 1989;16(11):1416\u201320.","journal-title":"J Rheumatol"},{"issue":"6","key":"1201_CR9","first-page":"859","volume":"19","author":"JG Brun","year":"1992","unstructured":"Brun JG, Haga HJ, Boe E, Kallay I, Lekven C, Berntzen HB, Fagerhol MK. Calprotectin in patients with rheumatoid arthritis: relation to clinical and laboratory variables of disease activity. J Rheumatol. 1992;19(6):859\u201362.","journal-title":"J Rheumatol"},{"issue":"6","key":"1201_CR10","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/030097402320817077","volume":"31","author":"TM Madland","year":"2002","unstructured":"Madland TM, Hordvik M, Haga HJ, Jonsson R, Brun JG. Leukocyte protein calprotectin and outcome in rheumatoid arthritis: a longitudinal study. Scand J Rheumatol. 2002;31(6):351\u20134.","journal-title":"Scand J Rheumatol"},{"issue":"8","key":"1201_CR11","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1136\/ard.2006.064741","volume":"66","author":"HB Hammer","year":"2007","unstructured":"Hammer HB, Odegard S, Fagerhol MK, Landew\u00e9 R, van der Heijde D, Uhlig T, et al. Calprotectin (a major leucocyte protein) is strongly and independently correlated with joint inflammation and damage in rheumatoid arthritis. Ann Rheum Dis. 2007;66(8):1093\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"1201_CR12","doi-asserted-by":"crossref","first-page":"R122","DOI":"10.1186\/ar3426","volume":"13","author":"L Andr\u00e9s Cerezo","year":"2011","unstructured":"Andr\u00e9s Cerezo L, Mann H, Pecha O, Ple\u0161tilov\u00e1 L, Pavelka K, Vencovsk\u00fd J, et al. Decreases in serum levels of S100A8\/9 (calprotectin) correlate with improvements in total swollen joint count in patients with recent-onset rheumatoid arthritis. Arthritis Res Ther. 2011;13(4):R122.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"1201_CR13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s40291-013-0016-9","volume":"17","author":"M Garc\u00eda-Arias","year":"2013","unstructured":"Garc\u00eda-Arias M, Pascual-Salcedo D, Ramiro S, Ueberschlag ME, Jermann TM, Cara C, et al. Calprotectin in rheumatoid arthritis : association with disease activity in a cross-sectional and a longitudinal cohort. Mol Diagn Ther. 2013;17(1):49\u201356.","journal-title":"Mol Diagn Ther"},{"issue":"6","key":"1201_CR14","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1373\/clinchem.2007.099549","volume":"54","author":"D Seny de","year":"2008","unstructured":"de Seny D, Fillet M, Ribbens C, Mar\u00e9e R, Meuwis MA, Lutteri L, et al. Monomeric calgranulins measured by SELDI-TOF mass spectrometry and calprotectin measured by ELISA as biomarkers in arthritis. Clin Chem. 2008;54(6):1066\u201375.","journal-title":"Clin Chem"},{"issue":"11","key":"1201_CR15","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1093\/rheumatology\/keg385","volume":"42","author":"D Foell","year":"2003","unstructured":"Foell D, Kane D, Bresnihan B, Vogl T, Nacken W, Sorg C, et al. Expression of the pro-inflammatory protein S100A12 (EN-RAGE) in rheumatoid and psoriatic arthritis. Rheumatology (Oxford). 2003;42(11):1383\u20139.","journal-title":"Rheumatology (Oxford)"},{"key":"1201_CR16","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/1471-2474-15-335","volume":"15","author":"HH Nordal","year":"2014","unstructured":"Nordal HH, Brun JG, Halse AK, Jonsson R, Fagerhol MK, Hammer HB. The neutrophil protein S100A12 is associated with a comprehensive ultrasonographic synovitis score in a longitudinal study of patients with rheumatoid arthritis treated with adalimumab. BMC Musculoskelet Disord. 2014;15:335.","journal-title":"BMC Musculoskelet Disord."},{"issue":"4","key":"1201_CR17","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3109\/03009742.2015.1107128","volume":"45","author":"HH Nordal","year":"2016","unstructured":"Nordal HH, Brun JG, Hordvik M, Eidsheim M, Jonsson R, Halse AK. Calprotectin (S100A8\/A9) and S100A12 are associated with measures of disease activity in a longitudinal study of patients with rheumatoid arthritis treated with infliximab. Scand J Rheumatol. 2016;45(4):274\u201381.","journal-title":"Scand J Rheumatol"},{"issue":"7","key":"1201_CR18","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/acr.22795","volume":"68","author":"J Inciarte-Mundo","year":"2016","unstructured":"Inciarte-Mundo J, Hern\u00e1ndez MV, Ruiz-Esquide V, Cabrera-Villalba SR, Ramirez J, Cuervo A, et al. Serum calprotectin versus acute-phase reactants in the discrimination of inflammatory disease activity in rheumatoid arthritis patients receiving tumor necrosis factor inhibitors. Arthritis Care Res (Hoboken). 2016;68(7):899\u2013906.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"1201_CR19","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1136\/ard.2008.103739","volume":"69","author":"HB Hammer","year":"2010","unstructured":"Hammer HB, Odegard S, Syversen SW, Landew\u00e9 R, van der Heijde D, Uhlig T, et al. Calprotectin (a major S100 leucocyte protein) predicts 10-year radiographic progression in patients with rheumatoid arthritis. Ann Rheum Dis. 2010;69(1):150\u20134.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"1201_CR20","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1177\/1759720X10378372","volume":"2","author":"S Srirangan","year":"2010","unstructured":"Srirangan S, Choy EH. The role of interleukin 6 in the pathophysiology of rheumatoid arthritis. Ther Adv Musculoskelet Dis. 2010;2(5):247\u201356.","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"7","key":"1201_CR21","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1136\/annrheumdis-2011-200975","volume":"71","author":"JE Gottenberg","year":"2012","unstructured":"Gottenberg JE, Dayer JM, Lukas C, Ducot B, Chiocchia G, Cantagrel A, et al. Serum IL-6 and IL-21 are associated with markers of B cell activation and structural progression in early rheumatoid arthritis: results from the ESPOIR cohort. Ann Rheum Dis. 2012;71(7):1243\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"16","key":"1201_CR22","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0024-3205(01)01264-4","volume":"69","author":"H Sone","year":"2001","unstructured":"Sone H, Sakauchi M, Takahashi A, Suzuki H, Inoue N, Iida K, et al. Elevated levels of vascular endothelial growth factor in the sera of patients with rheumatoid arthritis correlation with disease activity. Life Sci. 2001;69(16):1861\u20139.","journal-title":"Life Sci"},{"issue":"4","key":"1201_CR23","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/rheumatology\/keq378","volume":"50","author":"J Westra","year":"2011","unstructured":"Westra J, de Groot L, Plaxton SL, Brouwer E, Posthumus MD, Kallenberg CG, et al. Angiopoietin-2 is highly correlated with inflammation and disease activity in recent-onset rheumatoid arthritis and could be predictive for cardiovascular disease. Rheumatology (Oxford). 2011;50(4):665\u201373.","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"1201_CR24","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1002\/1529-0131(200109)44:9<2055::AID-ART355>3.0.CO;2-2","volume":"44","author":"S Ballara","year":"2001","unstructured":"Ballara S, Taylor PC, Reusch P, Marme D, Feldmann M, Maini RN, et al. Raised serum vascular endothelial growth factor levels are associated with destructive change in inflammatory arthritis. Arthritis Rheum. 2001;44(9):2055\u201364.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"1201_CR25","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1136\/ard.2004.023929","volume":"64","author":"E Naredo","year":"2005","unstructured":"Naredo E, Bonilla G, Gamero F, Uson J, Carmona L, Laffon A. Assessment of inflammatory activity in rheumatoid arthritis: a comparative study of clinical evaluation with grey scale and power Doppler ultrasonography. Ann Rheum Dis. 2005;64(3):375\u201381.","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"1201_CR26","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1136\/ard.2011.152926","volume":"70","author":"HB Hammer","year":"2011","unstructured":"Hammer HB, Bolton-King P, Bakkeheim V, Berg TH, Sundt E, Kongtorp AK, et al. Examination of intra and interrater reliability with a new ultrasonographic reference atlas for scoring of synovitis in patients with rheumatoid arthritis. Ann Rheum Dis. 2011;70(11):1995\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"1201_CR27","doi-asserted-by":"crossref","first-page":"R178","DOI":"10.1186\/ar3503","volume":"13","author":"HB Hammer","year":"2011","unstructured":"Hammer HB, Fagerhol MK, Wien TN, Kvien TK. The soluble biomarker calprotectin (a S100 protein) is associated to ultrasonographic synovitis scores and is sensitive to change in patients with rheumatoid arthritis treated with adalimumab. Arthritis Res Ther. 2011;13(5):R178.","journal-title":"Arthritis Res Ther"},{"key":"1201_CR28","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/s13075-015-0764-5","volume":"17","author":"J Hurnakova","year":"2015","unstructured":"Hurnakova J, Zavada J, Hanova P, Hulejova H, Klein M, Mann H, et al. Serum calprotectin (S100A8\/9): an independent predictor of ultrasound synovitis in patients with rheumatoid arthritis. Arthritis Res Ther. 2015;17:252.","journal-title":"Arthritis Res Ther."},{"key":"1201_CR29","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s13075-016-1032-z","volume":"18","author":"J Inciarte-Mundo","year":"2016","unstructured":"Inciarte-Mundo J, Ramirez J, Hern\u00e1ndez MV, Ruiz-Esquide V, Cuervo A, Cabrera-Villalba SR, et al. Calprotectin and TNF trough serum levels identify power Doppler ultrasound synovitis in rheumatoid arthritis and psoriatic arthritis patients in remission or with low disease activity. Arthritis Res Ther. 2016;18:160.","journal-title":"Arthritis Res Ther."},{"issue":"7","key":"1201_CR30","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/acr.22513","volume":"67","author":"A Baillet","year":"2015","unstructured":"Baillet A, Gossec L, Paternotte S, Etcheto A, Combe B, Meyer O, et al. Evaluation of serum interleukin-6 level as a surrogate marker of synovial inflammation and as a factor of structural progression in early rheumatoid arthritis: results from a French national multicenter cohort. Arthritis Care Res (Hoboken). 2015;67(7):905\u201312.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"1201_CR31","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cyto.2016.03.014","volume":"83","author":"AD do Prado","year":"2016","unstructured":"do Prado AD, Bisi MC, Piovesan DM, Bredemeier M, Batista TS, Petersen L, et al. Ultrasound power Doppler synovitis is associated with plasma IL-6 in established rheumatoid arthritis. Cytokine. 2016;83:27\u201332.","journal-title":"Cytokine"},{"issue":"12","key":"1201_CR32","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1093\/rheumatology\/keh380","volume":"43","author":"J Strunk","year":"2004","unstructured":"Strunk J, Heinemann E, Neeck G, Schmidt KL, Lange U. A new approach to studying angiogenesis in rheumatoid arthritis by means of power Doppler ultrasonography and measurement of serum vascular endothelial growth factor. Rheumatology (Oxford). 2004;43(12):1480\u20133.","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"1201_CR33","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3109\/s10165-008-0146-9","volume":"19","author":"D Kurosaka","year":"2009","unstructured":"Kurosaka D, Hirai K, Nishioka M, Miyamoto Y, Yoshida K, Takahashi E, et al. Correlation between synovial blood flow signals and serum vascular endothelial growth factor levels in patients with refractory rheumatoid arthritis. Mod Rheumatol. 2009;19(2):187\u201391.","journal-title":"Mod Rheumatol"},{"issue":"6","key":"1201_CR34","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.3899\/jrheum.090941","volume":"37","author":"D Kurosaka","year":"2010","unstructured":"Kurosaka D, Hirai K, Nishioka M, Miyamoto Y, Yoshida K, Noda K, et al. Clinical significance of serum levels of vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in patients with rheumatoid arthritis. J Rheumatol. 2010;37(6):1121\u20138.","journal-title":"J Rheumatol"},{"issue":"2","key":"1201_CR35","first-page":"637","volume":"52","author":"F Vreju","year":"2011","unstructured":"Vreju F, Ciurea M, Ro\u015fu A, Mu\u015fetescu A, Grecu D, Ciurea P. Power Doppler sonography, a non-invasive method of assessment of the synovial inflammation in patients with early rheumatoid arthritis. Rom J Morphol Embryol. 2011;52(2):637\u201343.","journal-title":"Rom J Morphol Embryol"},{"issue":"5","key":"1201_CR36","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1093\/rheumatology\/keq415","volume":"50","author":"SY Kawashiri","year":"2011","unstructured":"Kawashiri SY, Kawakami A, Iwamoto N, Fujikawa K, Satoh K, Tamai M, et al. The power Doppler ultrasonography score from 24 synovial sites or 6 simplified synovial sites, including the metacarpophalangeal joints, reflects the clinical disease activity and level of serum biomarkers in patients with rheumatoid arthritis. Rheumatology (Oxford). 2011;50(5):962\u20135.","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"1201_CR37","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jbspin.2012.09.001","volume":"80","author":"J Strunk","year":"2013","unstructured":"Strunk J, Rumbaur C, Albrecht K, Neumann E, M\u00fcller-Ladner U. Linking systemic angiogenic factors (VEGF, angiogenin, TIMP-2) and Doppler ultrasound to anti-inflammatory treatment in rheumatoid arthritis. Joint Bone Spine. 2013;80(3):270\u20133.","journal-title":"Joint Bone Spine"},{"issue":"3","key":"1201_CR38","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/rheumatology\/ket405","volume":"53","author":"SY Kawashiri","year":"2014","unstructured":"Kawashiri SY, Suzuki T, Nakashima Y, Horai Y, Okada A, Iwamoto N, et al. Ultrasonographic examination of rheumatoid arthritis patients who are free of physical synovitis: power Doppler subclinical synovitis is associated with bone erosion. Rheumatology (Oxford). 2014;53(3):562\u20139.","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"1201_CR39","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31(3):315\u201324.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"1201_CR40","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/art.1780380107","volume":"38","author":"ML Prevoo","year":"1995","unstructured":"Prevoo ML, van \u2019t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995;38(1):44\u20138.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"1201_CR41","first-page":"705","volume":"26","author":"AM Gestel van","year":"1999","unstructured":"van Gestel AM, Anderson JJ, van Riel PL, Boers M, Haagsma CJ, Rich B, et al. ACR and EULAR improvement criteria have comparable validity in rheumatoid arthritis trials. J Rheumatol. 1999;26(3):705\u201311.","journal-title":"J Rheumatol"},{"issue":"6","key":"1201_CR42","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/art.1780010604","volume":"1","author":"J Lansbury","year":"1958","unstructured":"Lansbury J. Report of a three-year study on the systemic and articular indexes in rheumatoid arthritis; theoretic and clinical considerations. Arthritis Rheum. 1958;1(6):505\u201322.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"1201_CR43","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1136\/annrheumdis-2013-203923","volume":"74","author":"IY Choi","year":"2015","unstructured":"Choi IY, Gerlag DM, Herenius MJ, Thurlings RM, Wijbrandts CA, Foell D, et al. MRP8\/14 serum levels as a strong predictor of response to biological treatments in patients with rheumatoid arthritis. Ann Rheum Dis. 2015;74(3):499\u2013505.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"1201_CR44","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s10067-004-0878-7","volume":"23","author":"F Salaffi","year":"2004","unstructured":"Salaffi F, Carotti M, Manganelli P, Filippucci E, Giuseppetti GM, Grassi W. Contrast-enhanced power Doppler sonography of knee synovitis in rheumatoid arthritis: assessment of therapeutic response. Clin Rheumatol. 2004;23(4):285\u201390.","journal-title":"Clin Rheumatol"},{"issue":"11","key":"1201_CR45","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.dld.2014.07.013","volume":"46","author":"L Guidi","year":"2014","unstructured":"Guidi L, Marzo M, Andrisani G, Felice C, Pugliese D, Mocci G, et al. Faecal calprotectin assay after induction with anti-tumour necrosis factor \u03b1 agents in inflammatory bowel disease: prediction of clinical response and mucosal healing at one year. Dig Liver Dis. 2014;46(11):974\u20139.","journal-title":"Dig Liver Dis"},{"issue":"12","key":"1201_CR46","first-page":"2239","volume":"54","author":"J Inciarte-Mundo","year":"2015","unstructured":"Inciarte-Mundo J, Ruiz-Esquide V, Hern\u00e1ndez MV, Ca\u00f1ete JD, Cabrera-Villalba SR, Ramirez J, et al. Calprotectin more accurately discriminates the disease status of rheumatoid arthritis patients receiving tocilizumab than acute phase reactants. Rheumatology (Oxford). 2015;54(12):2239\u201343.","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"1201_CR47","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1189\/jlb.69.6.986","volume":"69","author":"Z Yang","year":"2001","unstructured":"Yang Z, Tao T, Raftery MJ, Youssef P, Di Girolamo N, Geczy CL. Proinflammatory properties of the human S100 protein S100A12. J Leukoc Biol. 2001;69(6):986\u201394.","journal-title":"J Leukoc Biol"},{"issue":"10","key":"1201_CR48","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.1182\/blood-2008-05-155846","volume":"112","author":"N Nishimoto","year":"2008","unstructured":"Nishimoto N, Terao K, Mima T, Nakahara H, Takagi N, Kakehi T. Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease. Blood. 2008;112(10):3959\u201364.","journal-title":"Blood"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-016-1201-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T18:19:29Z","timestamp":1692641969000},"score":1,"resource":{"primary":{"URL":"http:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-016-1201-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,12]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1201"],"URL":"https:\/\/doi.org\/10.1186\/s13075-016-1201-0","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,12]]},"article-number":"3"}}